老年急性髓系白血病患者临终医疗资源使用情况
该研究基于美国1999至2011年诊断且2012年底前死亡的≥66岁急性髓系白血病(AML)患者,利用医保索赔数据分析临终关怀与积极治疗模式。结果显示临终关怀使用率从1999年31.3%升至2012年56.4%,但主要因生命最后7天内才首次入组临终关怀;生命最后14天内化疗使用率从7.7%升至18.8%。作者认为老年AML患者临终照护不理想,需进一步研究。
要点
- 临终关怀使用率从1999年31.3%升至2012年56.4%,但增长主要来自生命最后7天内的晚期入组。
- 在5,847例入组临终关怀的患者中,47.4%在生命最后7天、28.8%在最后3天才首次入组。
- 生命最后14天内化疗使用率从1999年7.7%升至2012年18.8%。
核心结论
- 老年AML患者的临终照护不理想。
- 作者认为需要进一步研究以明确其临终关怀服务使用率低的原因及改善策略。
研究设计与样本
- 基于人群的回顾性队列研究。
- 纳入诊断时≥66岁、1999年至2011年诊断且2012年12月31日前死亡的AML患者,共13,156例。
- 使用医保索赔数据评估临终关怀与积极治疗模式,采用多变量logistic回归分析预测因素。
主要发现
- 总体队列(N=13,156)中,AML诊断后临终关怀使用率从1999年31.3%升至2012年56.4%。
- 在5,847例入组临终关怀的患者中,47.4%在生命最后7天、28.8%在最后3天首次入组临终关怀。
- 在临终关怀进出转换的患者中,62%在临终关怀外接受输血。
- 生命最后14天内化疗使用率从1999年7.7%升至2012年18.8%。
- 男性及非白人患者临终关怀入组可能性更低,临终化疗或重症监护病房入住可能性更高;年龄更大患者临终化疗或重症监护病房入住可能性更低,临终关怀入组可能性更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Little is known about the patterns and predictors of the use of end-of-life health care among patients with acute myeloid leukemia (AML). End-of-life care is particularly relevant for older adults with AML because of their poor prognosis. Methods We performed a population-based, retrospective cohort study of patients with AML who were ≥ 66 years of age at diagnosis and diagnosed during the period from 1999 to 2011 and died before December 31, 2012. Medicare claims were used to assess patterns of hospice care and use of aggressive treatment. Predictors of these end points were evaluated using multivariable logistic regression analyses. Results In the overall cohort (N = 13,156), hospice care after AML diagnosis increased from 31.3% in 1999 to 56.4% in 2012, but the increase was primarily driven by late hospice enrollment that occurred in the last 7 days of life. Among the 5,847 patients who enrolled in hospice, 47.4% and 28.8% started their first hospice enrollment in the last 7 and 3 days of life, respectively. Among patients who transferred in and out of hospice care, 62% received transfusions outside hospice. Additionally, the use of chemotherapy within the last 14 days of life increased from 7.7% in 1999 to 18.8% in 2012. Patients who were male and nonwhite were less likely to enroll in hospice and more likely to receive chemotherapy or be admitted to intensive care units at the end of life. Conversely, older patients were less likely to receive chemotherapy or have intensive care unit admission at the end of life, and were more likely to enroll in hospice. Conclusion End-of-life care for older patients with AML is suboptimal. Additional research is warranted to identify reasons for their low use of hospice services and strategies to enhance end-of-life care for these patients.
引用
- Wang R, Zeidan AM, Halene S, et al. Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life. J Clin Oncol. 2017. PMID: 28783450. doi:10.1200/JCO.2017.72.7149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。